Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

BAER 101

Next Previous
X
Search
Drug Profile

BAER 101

Alternative Names: AZ-7325; AZD-7325; BAER 101

Latest Information Update: 19 Aug 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator AstraZeneca; University College London
  • Developer AstraZeneca; Avenue Therapeutics; Cincinnati Childrens Hospital Medical Center; University College London
  • Class Anxiolytics; Behavioural disorder therapies; Neuroprotectants; Nootropics; Small molecules
  • Mechanism of Action GABA A alpha 2 receptor modulators; GABA A alpha 3 receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Anxiety disorders
  • Preclinical Absence epilepsy
  • No development reported Fragile X syndrome; Neurological disorders; Pervasive child development disorders

Most Recent Events

  • 09 Aug 2024 Avenue Therapeutics plans a phase IIa trial for Partial-epilepsies
  • 22 Feb 2024 Pharmacodynamics and adverse event data from a preclinical trial in Absence epilepsy released by Avenue Therapeutics
  • 01 Aug 2023 Avenue Therapeutics plans a phase IIa trial Absence epilepsy (PO) in 2024

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top